SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000890465-13-000025
Filing Date
2013-09-30
Accepted
2013-09-30 18:23:38
Documents
1
Period of Report
2013-09-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 27426
  Complete submission text file 0000890465-13-000025.txt   28741
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address
Nader Francois (Reporting) CIK: 0001365343 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23272 | Film No.: 131124521